APA (7th ed.) Citation

Taglialatela, I., Negrini, L., Martini, V., Conte, B., Landolfo, T., Ruffilli, B., . . . Gennari, A. (2025). 311P Exploring circulating MDSC role in immune-related adverse events (irAEs) in early triple-negative breast cancer (eTNBC): A preliminary analysis from the IRIS study. Annals of Oncology, 36, S331. https://doi.org/10.1016/j.annonc.2025.08.740

Chicago Style (17th ed.) Citation

Taglialatela, I., et al. "311P Exploring Circulating MDSC Role in Immune-related Adverse Events (irAEs) in Early Triple-negative Breast Cancer (eTNBC): A Preliminary Analysis from the IRIS Study." Annals of Oncology 36 (2025): S331. https://doi.org/10.1016/j.annonc.2025.08.740.

MLA (9th ed.) Citation

Taglialatela, I., et al. "311P Exploring Circulating MDSC Role in Immune-related Adverse Events (irAEs) in Early Triple-negative Breast Cancer (eTNBC): A Preliminary Analysis from the IRIS Study." Annals of Oncology, vol. 36, 2025, p. S331, https://doi.org/10.1016/j.annonc.2025.08.740.